Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fennec Pharmaceuticals (FENC) Shares Outstanding (Diluted Average) (2016 - 2025)

Fennec Pharmaceuticals filings provide 16 years of Shares Outstanding (Diluted Average) readings, the most recent being $28.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 4.7% to $28.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.6 million, a 4.7% increase, with the full-year FY2025 number at $28.6 million, up 4.7% from a year prior.
  • Shares Outstanding (Diluted Average) hit $28.6 million in Q4 2025 for Fennec Pharmaceuticals, up from $27.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $31.1 million in Q1 2024 to a low of $26.0 million in Q1 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $26.6 million (2023), compared with a mean of $27.1 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 109611.44% in 2021 and later fell 11.3% in 2025.
  • Fennec Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $26.0 million in 2021, then increased by 1.03% to $26.3 million in 2022, then grew by 1.14% to $26.6 million in 2023, then rose by 2.71% to $27.3 million in 2024, then grew by 4.7% to $28.6 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $28.6 million (Q4 2025), $27.7 million (Q3 2025), and $27.7 million (Q2 2025) per Business Quant data.